1 |
Steingrimsson, E., Copelan, N. G. and Jenkina, N. A. (2004) Melanocytes and the microphthalmia transcription factor network. Annu. Rev. Genet. 38, 365-411.
DOI
|
2 |
Sato, K. and Toriyama, M. (2011) The inhibitory effect of non-steroidal anti-inflammatory drugs (NSAIDs) on the monophenolase and diphenolase activities of mushroom tyrosinase. Int. J. Mol. Sci. 12, 3998-4008.
DOI
|
3 |
Bertolotto, C., Abbe, P., Hemesath, T. J., Bille, K., Fisher, D. E., Ortonne, J.-P. and Ballotti, R. (1998) Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell Biol. 142, 827-835.
DOI
|
4 |
Decher, H., Schweikardt, T. and Tuczek, F. (2006) The first crystal structure of tyrosinase: all questions answered? Angew. Chem. Int. Ed. Engl. 45, 4546-4550.
DOI
|
5 |
Ezzedine, K., Lim, H. W., Suzuki, T., Katayama, I., Hamzavi, I., Lan, C. C. E., Goh, B. K., Anbar, T., Silva de Castro, C., Lee, A. Y., Parsad, D., van Geel, N., Le Poole, I. C., Oiso, N., Benzakri, L., Spritz, R., Gauthier, Y., Hann, S. K., Picardo, M. and Taieb, A.; Vitiligo Global Issue Consensus Conference Panelists (2012) Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Malanoma Res. 25, E1-E13.
|
6 |
Jackson, I. J., Chambers, D. M., Tsukamoto, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A. and Hearing, V. (1992) A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J. 11, 527-535.
DOI
|
7 |
Korner, A. and Pawelek, J. (1982) Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217, 1163-1165.
DOI
|
8 |
Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔC(T) method. Methods 25, 402-408.
DOI
|
9 |
Matoba, Y., Kumagai, T., Yamamoto, A., Yoshitsu, H. and Sugiyama, M. (2006) Crystallographic evidence that the dinuclear copper center of tyrosinase is flexible during catalysis. J. Biol. Chem. 281, 8981-8990.
DOI
|
10 |
Michalska-Malecka, K., Regucka, A., Spiewak, D., Sosnowska-Ponska, M. and Niewiem, A. (2016) Does the use of acetylsalicylic acid have an influence on our vision? Clin. Interv. Aging 11, 1567-1574.
DOI
|
11 |
Nicolaidou, E. and Katsambas, A. D. (2014) Pigmentation disorders: hyperpigmentation and hypopigmentation. Clin. Dermatol. 32, 66-72.
DOI
|
12 |
Nishio, T., Usami, M., Awaji, M., Shinohara, S. and Sato, K. (2016) Dual effects of acetylsalicylic acid on ERK signaling and Mitf transcription lead to inhibition of melanogenesis. Mol. Cell. Biochem. 412, 101-110.
DOI
|
13 |
Niu, C. and Aisa, H. A. (2017) Upregulation of melanogenesis and tyrosinase activity: potential agents for vitiligo. Molecules 22, 1303.
DOI
|
14 |
Piazuelo, E. and Lanas, A. (2015) NSAIDs and gastrointestinal cancer. Prostaglandins Other Lipid Mediat. 120, 91-96.
DOI
|
15 |
Sato, K., Takahashi, H. and Toriyama, M. (2011) Depigmenting mechanism of NSAIDs on B16F1 melanoma cells. Arch. Dermatol. Res. 303, 171-180.
DOI
|
16 |
Seetha, A., Devaraj, H. and Sudhandiran, G. (2020) Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J. Biochem. Mol. Toxicol. 34, e22433.
DOI
|
17 |
Tsukamoito, K., Jackson, I. J., Urabe, K., Montague, P. M. and Hearing, V. J. (1992) A second tyrosinase related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J. 11, 519-526.
DOI
|
18 |
Yiannakopoulou, E. C. (2015) Aspirin and NSAIDs for breast cancer chemoprevention. Eur. J. Cancer Prev. 24, 416-421.
DOI
|
19 |
Alhashimi, M., Mayhoub, A. and Seleem, M. N. (2019) Repurposing salicylamide for combating multidrug-resistant Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 63, e01225-19.
|
20 |
Butenas, S., Cawthern, K. M., van't Veer, C., DiLorenzo, M. E., Lock, J. B. and Mann, K. G. (2001) Antiplatelet agents in tissue factorinduced blood coagulation. Blood 97, 2314-2322.
DOI
|
21 |
Desborough, M. J. R. and Keeling, D. M. (2017) The aspirin story-from willow to wonder drug. Br. J. Haematol. 177, 674-683.
DOI
|
22 |
Kameyama, K., Takemura, T., Hamada, Y., Sakai, C., Kondoh, S., Nishiyama, S., Urabe, K. and Hearing V. J. (1993) Pigment production in murine melanoma cells in regulated by tyrosinase-related protein-1 (TRP-1), DOPAchrome tautomerase (TRP-2), and a melanogenic inhibitor. J. Invest. Dermatol. 100, 126-131.
DOI
|
23 |
Kumar, D., Rahman, H., Tyagi, E., Liu, T., Li, C., Lu, R., Lum, D., Holmen, S. L., Maschek, J. A., Cox, J. E., VanBrocklin, M. W. and Grossman, D. (2018) Aspirin suppresses PGE2 and activates AMP kinase to inhibit melanoma cell motility, pigmentation, and selective tumor growth in vivo. Cancer Prev. Res. 11, 629-642.
DOI
|
24 |
Scherschun, L., Kim, J. J. and Lim, H. W. (2001) Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J. Am. Acad. Dermatol. 44, 999-1003.
DOI
|
25 |
Shi, T., Fujita, K., Gong, J., Nakahara, M., Iwama, H., Liu, S, Yoneyama, H., Morishita, A., Nomura, T., Tani, J., Takuma, K., Tadokoro, T., Himoto, T., Oura, K., Tsutsui, K., Kobara, H. and Masaki, T. (2020) Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis. Oncol. Rep. 44, 457-468.
DOI
|
26 |
Ullah, S., Chung, C. C. and Hyun, C.-G. (2020) Induction of melanogenesis by fosfomycin in B16F10 cells through the upregulation of P-JNK and P-p38 signaling pathways. Antibiotics (Basel) 9, 172.
DOI
|
27 |
Weissmann, G. (1991) Aspirin. Sci. Am. 264, 84-90.
DOI
|
28 |
Zappavigna, S., Cossu, A. M., Grimaldi, A., Bocchetti, M., Ferraro, G. A., Nicoletti, G. F., Filosa, R. and Caraglia, M. (2020) Anti-inflammatory drugs as anticancer agents. Int. J. Mol. Sci. 21, 2605.
DOI
|
29 |
Sato, K., Takahashi, H., Iraha, R. and Toriyama, M. (2008) Down-regulation of tyrosinase expression by acetylsalicylic acid in murine B16 melanoma. Biol. Pharm. Bull. 31, 33-37.
DOI
|
30 |
Chowdhury, K. H., Chowdhury, M. R., Mahmud, S., Tareq, A. M., Hanif, N. B., Banu, N., Reza, A. S. M. A., Emran, T. B. and Simal-Gandara, J. (2021) Drug repurposing approach against novel coronavirus disease (COVID-19) through virtual screening targeting SARS-CoV-2 main protease. Biology (Basel) 10, 2.
|
31 |
Abdel-Rahman, M. S., Reddi, A. S., Curro, F. A., Turkall, R. M., Kadry, A. M. and Hansrote, J. A. (1991) Bioavailability of aspirin and salicylamide following oral co-administration in human volunteers. Can. J. Physiol. Pharmacol. 69, 1436-1442.
DOI
|
32 |
Alikhan, A., Felsten, L. M., Daly, M. and Petronic-Rosic, V. (2011) Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J. Am. Acad. Dermatol. 65, 473-491
DOI
|
33 |
Kim, D., Kim, H. J. and Jun, H. S. (2020) Polygonum multiflorum Thunb. extract stimulates melanogenesis by induction of COX2 expression through the activation of p38 MAPK in B16F10 mouse melanoma cells. Evid. Based Complement. Alternat. Med. 2020, 7642019.
|